86-025-86819862  |     sales@jinchemical.com
  • 中文

Nanjing Shunxiang Pharmaceutical Technology Co.,Ltd

Global Certified

ISO 9001:2000

Winner

Founded in 1999

  • Home
  • About Us
  • Products
  • Factory Tour
  • News
  • Contact Us

PPTS: Cornerstone Role in High-Value-Added Synthesis and Substitution Dilemma

by shunxiang / Friday, 24 July 2026 / Published in news

The development prospects of p-toluenesulfonic acid pyridinium salt (PPTS) are robust, driven primarily by green synthesis, drug R&D, and polymer material upgrades. However, its growth is constrained by niche application scenarios and competitive alternatives, classifying it as a “key enabling reagent” rather than a bulk chemical. ‌‌
Clear Application Prospects: As a mild, anhydrous, and selective acidic catalyst, PPTS is indispensable in hydroxyl protection/deprotection (acetalization, silylation), drug and natural product synthesis, and late-stage modification of complex molecules, particularly meeting the stringent requirements for functional group tolerance in current pharmaceutical and high-end material applications. In recent years, it has also gained prominence in controlled polymerization and functionalization modification.

Green and Process Advantages Support Position: Compared to concentrated sulfuric acid or p-toluenesulfonic acid, PPTS exhibits low corrosiveness, simple post-treatment, easy solid-state weighing, and mild reaction conditions, aligning with the trend of green chemistry. However, its strong hygroscopicity and tendency to decompose upon moisture exposure impose high requirements for storage and reaction system dryness, limiting its large-scale replacement in wet-process applications. ‌‌

Challenges and Boundaries: Lacking significant technological disruption, it primarily serves as a “laboratory staple reagent” or midstream intermediate, rarely used in ton-scale industrial reactions. The emergence of more efficient, stable, or recyclable alternatives (e.g., functionalized ionic liquids or solid acids) could erode its market share, but in the short term, it remains difficult to replace in high-value-added syntheses (e.g., peptides, glycobiology, mRNA lipid nanoparticle precursors).

R1: “Gel” must be translated as gel. The key factors for the next five years are: ① The R&D progress of innovative drugs (particularly ADCs, oligonucleotides, and macrocycles); ② Whether the industrialization of high-performance polymers (such as degradable polyesters and smart gels) will drive demand for mild catalysis. If both trends continue to gain momentum, PPTS will firmly maintain its position as an “indispensable tool-type reagent” but will not experience explosive growth.

In summary, PPTS is not a hot trend but a “stable cornerstone” in the ecosystem of fine organic synthesis. Its development prospects depend on sustained investment in high-end chemical manufacturing and life sciences, rather than its own capacity expansion.

In the “tool-type reagent” sector of PPTS, Nanjing Shunxiang is not merely a manufacturer but a professional partner with scalable production capacity, international quality standards, and continuous process optimization capabilities. For R&D institutions and production enterprises requiring stable supply of high-purity PPTS, Nanjing Shunxiang undoubtedly stands out as a viable option to consider in the supply chain.

  • Tweet

Product

  • Chemical Synthesis
  • Bio Synthesis

Key Products

  • Di-tert-butyl dicarbonate
  • Diisopropyl azodicarboxylate
  • Pyridine sulfur trioxide
  • Pyridinium tribromide
  • Di-tert-Butyl azodicarboxylate
  • Pyridine hydrochloride
  • Pyridinium toluene-4-sulphonate
  • Pyridine hydrobromide
  • 1,3-Dimethyladamantane
  • tert-Butyl carbazate

CONTACT US

 

E-mail:

sales@jinchemical.com

Phone:

86-25-86819868

WhatsApp ID:

86-13813029728

Marketing:

86-13913839793
86-13951004015

Factory:

86-15261890999

Zip Code:

210018

 

Addree:

E,19 floor,Deji Mansion Building,188 Changjiang Road,Nanjing,China

Friendlink:  globalchemmade   guidechem   TengXiang   chemmade   chemicalbook

2019 © Nanjing Shunxiang Pharmaceutical Technology Co.,Ltd. All Rights Reserved.

TOP